Bone ‐targeted delivery of TGF‐β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati–Engelmann disease

Annals of the New York Academy of Sciences, EarlyView.
Source: Annals of the New York Academy of Sciences - Category: Science Authors: Source Type: research
More News: Academies | Science